Surgery Partners (NASDAQ:SGRY) Issues Quarterly Earnings Results

Surgery Partners (NASDAQ:SGRY) issued its quarterly earnings results on Monday. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.10), Zacks reports. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners updated its FY 2025 guidance to EPS.

Surgery Partners Stock Down 2.1%

SGRY opened at $22.20 on Monday. The company has a market capitalization of $2.85 billion, a P/E ratio of -46.25, a P/E/G ratio of 19.21 and a beta of 1.96. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The firm’s fifty day moving average price is $22.61 and its two-hundred day moving average price is $23.37. Surgery Partners has a fifty-two week low of $19.50 and a fifty-two week high of $33.97.

Analyst Ratings Changes

A number of equities analysts recently issued reports on SGRY shares. Macquarie dropped their target price on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 11th. Benchmark restated a “buy” rating and issued a $35.00 price target on shares of Surgery Partners in a research report on Monday, April 21st. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $35.00 price objective on shares of Surgery Partners in a research report on Tuesday, March 25th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $34.75.

Insider Activity

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the completion of the transaction, the insider now owns 63,408 shares in the company, valued at $1,527,498.72. This trade represents a 4.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO David T. Doherty sold 6,733 shares of Surgery Partners stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now directly owns 150,868 shares in the company, valued at $3,623,849.36. The trade was a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.30% of the company’s stock.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.